Heartstitch, Inc.

Heartstitch, Inc.
About Us
Follow us:
Share:
Subscribe:

About Us

About HeartStitch: HeartStitch®, Inc. was founded by Prof. Anthony Nobles with the intent of leveraging its technologies in the structural heart marketplace. HeartStitch® is focused on the innovative suture-based systems for remotely providing suture repair of structural heart defects and other vascular structures. HeartStitch® manufactures and markets the NobleStitch™ EL under and exclusive license from Nobles Medical Technologies II, Inc. NobleStitch™ EL is FDA cleared for vascular suturing in the United States and CE Marked for cardio-vascular suturing and PFO closure in the European Union. HeartStitch® is a registered trademark of HeartStitch®, Inc. For more on HeartStitch® visit www.HeartStitch.com

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

NobleStitch™ EL Sales Launch in Italy

Tue, Apr 19, 2016 14:06 CET

First Italian NobleStitch™ EL Case Successfully PerformedRome, Italy—Tuesday, April 19, 2016— Nobles Medical Technologies II, Inc. (NMT2) today announced that Prof. Cesare Greco, Associate Professor of Cardiology, Sapienza University of Rome consulting with Prof. Carlo Gaudio of the Policlinico Umberto 1, Rome, Italy successfully performed the first ever suture based percutaneous PFO closure in Italy using the NobleStitch™ EL. Reported in . This marks the official sales release of the NobleStitch™ EL in Italy. Dr. Michael

There are no items matching the current filter

There are no more items matching the current filter

Back to top

Share

About Us

NobleStitch™ EL Sales Launch in Italy